MigraineNCT07328685
Basic Body Awareness Therapy in Individuals With Migraine
A study testing Exercise and Standart therapy in people with Migraine, run by Mustafa Kemal University at 1 site in Turkey (Türkiye).
Trial summary
One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Migraine
- What is being tested?
- Exercise and Standart therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 2 Jan 2026to 1 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Diagnosed with migraine,
- Experiencing at least 3 migraine attacks per month,
- Between the ages of 18 and 55 and who volunteer to participate in the study.
Who cannot join
- History of secondary headaches,
- Being pregnant,
- Having any other neurological disease besides migraine,
- Having other secondary headaches in addition to migraine,
- History of malignancy,
- Regularly practicing meditation, yoga, or mindfulness-based practices.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Hatay Mustafa Kemal University
Antakya, Hatay, 31060
Yasemin Karaaslan, ptyasemindeveci@gmail.com
About this study
Official title: Examining the Effectiveness of Basic Body Awareness Therapy in Individuals With Migraine
One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the Jenkins Sleep Scale (JUS), and quality of life using the Headache Impact Test. Assessment of functional status, sleep quality, and quality of life will be performed before treatment and after treatment (at the end of week 8).
- Conditions
- Migraine
- Being tested
- Exercise, Standart therapy
- Keywords
- migraine, functional status, sleep, quality of life
- Medical subject headings
- Migraine Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseBehavioural
Participants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population.
Standart therapyBehavioural
Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.
| Study group | Role | What they receive |
|---|---|---|
| Body Awareness Therapy Plus Standard Treatment | Experimental | Participants in this group will receive body awareness therapy in addition to standard treatment. The exercise program will be implemented twice over an eight-week period. Receives: Behavioral: Exercise; Behavioral: Standart therapy |
| Standart Treatment | Active comparator | Participants in this group will receive standard treatment without the additional body awareness therapy. Receives: Behavioral: Standart therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Diary
The severity, duration, and frequency of headaches during attacks will be recorded daily by the participants.
Measured: Individuals will be asked to regularly complete a pain diary during the 4-week period before the program, during the program, and during the 4-week follow-up period after the training is completed.
Secondary outcomes (3)
Functional status
The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine.
Measured: Baseline and at the end of the 8-week intervention
Sleep quality
Individuals' sleep quality will be assessed using the Jenkins Sleep Scale.
Measured: Baseline and at the end of the 8-week intervention
Quality of life related to headaches.
The Headache Impact Test will be used to assess the impact of headache on quality of life.
Measured: Baseline and at the end of the 8-week intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2026
- Study start2 Jan 2026
- Primary completion20 Mar 2026
- Study completion1 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MigraineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mustafa Kemal University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yasemin KARAASLAN, Mustafa Kemal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07328685
- Sponsor's protocol ID
- HMKU-BBAT-2026
- Status last verified
- May 2026
- First submitted
- 27 Dec 2025
- Last updated
- 27 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining the Effectiveness of Basic Body Awareness Therapy in Individuals With Migraine
- ClinicalTrials.gov ID
- NCT07328685
- Acronym / sponsor ID
- HMKU-BBAT-2026
- Conditions
- Migraine
- Keywords
- migraine, functional status, sleep, quality of life
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Mustafa Kemal UniversityUniversity, hospital or other
- Study start
- 2 Jan 2026 (actual)
- Primary completion
- 20 Mar 2026 (actual)
- Study completion
- 1 Nov 2026 (estimated)
- First posted
- 9 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the Jenkins Sleep Scale (JUS), and quality of life using the Headache Impact Test. Assessment of functional status, sleep quality, and quality of life will be performed before treatment and after treatment (at the end of week 8).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Body Awareness Therapy Plus Standard Treatment | Experimental | Behavioral: Exercise, Behavioral: Standart therapyParticipants in this group will receive body awareness therapy in addition to standard treatment. The exercise program will be implemented twice over an eight-week period. |
| Standart Treatment | Active comparator | Behavioral: Standart therapyParticipants in this group will receive standard treatment without the additional body awareness therapy. |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Diagnosed with migraine,
- Experiencing at least 3 migraine attacks per month,
- Between the ages of 18 and 55 and who volunteer to participate in the study.
Key exclusion criteria (6 listed)
- History of secondary headaches,
- Being pregnant,
- Having any other neurological disease besides migraine,
- Having other secondary headaches in addition to migraine,
- History of malignancy,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExerciseParticipants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population. | Behavioural | Body Awareness Therapy Plus Standard Treatment |
| Standart therapyStandard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals. | Behavioural | Body Awareness Therapy Plus Standard Treatment, Standart Treatment |
Primary outcome
Pain Diary
Time frame: Individuals will be asked to regularly complete a pain diary during the 4-week period before the program, during the program, and during the 4-week follow-up period after the training is completed.
The severity, duration, and frequency of headaches during attacks will be recorded daily by the participants.
3 secondary outcomes
Functional status
Time frame: Baseline and at the end of the 8-week intervention
Sleep quality
Time frame: Baseline and at the end of the 8-week intervention
Quality of life related to headaches.
Time frame: Baseline and at the end of the 8-week intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Migraine
Active, not recruitingObservational study
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Migraine
Active, not recruitingObservational study
Consistency of Response With Rimegepant in Acute Treatment of Migraine
Migraine
RecruitingObservational study
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Migraine
RecruitingPhase 3
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
Post Traumatic Headache
Active, not recruiting
Cocoa Extract for Migraine Trial
Migraine
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise and Standart therapy in people with Migraine, run by Mustafa Kemal University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yasemin Karaaslan, PhD (0535 845 96 25, ptyasemindeveci@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Diary (time frame: Individuals will be asked to regularly complete a pain diary during the 4-week period before the program, during the program, and during the 4-week follow-up period after the training is completed.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.